I will read the article, but in comparison to those that make it to a cath lab the results are much higher (at least according to AHA). Thus the reason the debate of fibro vs. cath.
Most areas that I have seen in the past three to five years, has drastically reduced fibro therapy to rarely ever given if there is any possibility of cath. Most physicians will agree to take the chance of transporting to a cath lab over fibro. Usually the determination will be made of the severity of the AMI. The patients disposition of pain, cardiac markers, ECG (such as "tombstone", widowmaker, and involvement) and general clinical observation (will they make it or not). Thus the dilemma and the roll of the dice.
Like I described I have seen fibro given albeit it is now less than a quarter of the time it was given three years ago.
I first gave fibro (TpA) in the field as a FDA trial in the mid 80's. We did not even have XII lead, but performed multi 9 lead. The closest true CCU was about 25 miles and cath lab was over 60 miles away. Definitely, could tell which was placebo and which was real. No one knew much about reperfusion then and was scary the first time you witnessed it.
I know of Springfield MO EMS (where Bob Page is located) was using TKAse in certain circumstances with great results. I do not know if the protocol still exists or if they too have started using cath lab protocols too.
R/r 911